Navigation Links
IRIDEX Reports Improved Third Quarter 2010 Financial Results
Date:11/4/2010

MOUNTAIN VIEW, Calif., Nov. 4, 2010 /PRNewswire-FirstCall/ -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the third quarter ended October 2, 2010.

  • Earnings of $0.9 million or $0.09 per diluted share, up from $0.6 million or $0.07 per diluted share reported in the third quarter 2009.
  • Total sales increased 4.0% to $10.8 million, exceeding the range of $10.0 million to $10.2 million provided in prior guidance. Sequentially, revenues grew 9.4% from $9.9 million in the 2010 second quarter.
  • Gross margin was 48.5%, exceeding guidance range of 45% to 48%, operating expenses were $4.4 million within the guidance range of $4.3 million to $4.5 million.
  • Guidance for fourth quarter: revenue between $11.0 million and $11.2 million, gross margins between 45% and 48% and operating expenses between $4.6 million and $4.8 million.

  • "Our performance improved in the third quarter. Excluding OEM revenue, our Ophthalmology business grew 5.8% from $7.4 million in the third quarter of 2009 to $7.9 million this quarter, and it was most rewarding to see our ophthalmology consumable revenues return to growth.  Consumables are an important part of our overall growth strategy as are strategic acquisitions," stated Mr. Theodore A. Boutacoff, President and CEO. "Gross margin was above our guidance range due to favorable product mix and volume efficiencies and we continue to manage our operating expenses well."

    "Our largest trade show, the Annual Meeting of the American Academy of Ophthalmology, was in October and we were extremely pleased with the improved business activity at the Academy with sales and leads generated at this meeting increasing significantly over the prior year, which we believe is indicative of a turnaround in the worldwide economies and an increasing interest in our wider product offering," continued Mr. Boutacof
    '/>"/>

    SOURCE IRIDEX Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine technology :

    1. IRIDEX Announces Third Quarter 2010 Conference Call and Release Date
    2. IRIDEX Announces Commercial Availability of New Adjustable & Intuitive EndoProbe® Device for Eye Surgery
    3. IRIDEX Announces Second Quarter 2010 Conference Call and Release Date
    4. IRIDEX Granted U.S. Patent for Adjustable Laser Probe for Eye Surgery
    5. IRIDEX Announces First Commercial Shipment of New IQ 532(TM) Laser Systems
    6. IRIDEX Announces First Quarter 2010 Conference Call and Release Date
    7. IRIDEX Reports Fourth Quarter and Full Year 2009 Financial Results
    8. IRIDEX Announces Fourth Quarter and Full Year 2009 Conference Call and Release Date
    9. Ruediger Naumann-Etienne Appointed to IRIDEX Board of Directors
    10. IRIDEX Introduces IQ 532 Dual Port Green Laser System at the American Academy of Ophthalmology
    11. IRIDEX Introduces Modular Multi-Wavelength Laser Solution at the American Academy of Ophthalmology
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)...  The American Diabetes Association is recommending a ... with diabetes and that all people with diabetes ... in keeping with recent changes to guidelines for ... of Cardiology (ACC) and American Heart Association (AHA). ... changes to the Association,s annual revised Standards of ...
    (Date:12/22/2014)... JUNCTION, N.J. , Dec. 22, 2014 /PRNewswire/ ... company marketing its CytoSorb® blood purification technology to ... surgery patients in 28 countries worldwide, today announced ... Russo , MD, FACS, as its Senior Vice ... Dr. Di Russo ...
    (Date:12/22/2014)... Research and Markets ( http://www.researchandmarkets.com/research/hmlfbq/investment ... "Investment Analysis of the US Medical Device Sector ... http://photos.prnewswire.com/prnh/20130307/600769 This ... sector identifies the key trends and rationale for ... mergers and acquisitions. The study will ...
    Breaking Medicine Technology:New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5Investment Analysis of the US Medical Device Sector 2
    ... , OMAHA, Neb., Dec. 4 Amber ... Accreditation Commission for Health Care, Inc. (ACHC) for specialized ... provided comprehensive pharmacy care programs and services to meet ... one of the leading providers of services to transplant ...
    ... , ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE ... against biological and chemical threats, announced today the presentation of ... its lyophilized recombinant Protective Antigen (rPA) based anthrax vaccine is ... up to and including 55 degrees C. The data ...
    Cached Medicine Technology:Amber Pharmacy Earns Accreditation From ACHC 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5
    (Date:12/25/2014)... TX (PRWEB) December 26, 2014 The ... to 2023” focuses on the current treatment landscape, unmet ... cancer market. TS-1 is an anti-cancer drug which is ... orally and is also used for treating gastric cancer ... and otastat potassium. The drug was first approved in ...
    (Date:12/25/2014)... The short film “Color of Honor” by ... of a true 9/11 hero, Welles Remy Crowther. It has ... 24 hours of Nuremberg International Short Film Festival and the ... Actress, screenwriter and director Luciana Lagana plays the mother ... her husband, Gregory Graham - Graham plays a ...
    (Date:12/25/2014)... December 25, 2014 Recently, LunaDress.co.uk has updated its ... and related accessories. Now, all of the models at LunaDress.co.uk come ... a groom lifts the wedding veil can turn out to be ... charm. A wedding veil can always bring surprise to a wedding. ... on how to choose veils for a big day . ...
    (Date:12/25/2014)... Dennis Thompson HealthDay Reporter ... be closing in on a "fountain of youth" drug that ... of older adults, a new study suggests. Seniors received ... drug that targets a genetic signaling pathway linked to aging ... The experimental medication, a version of the ...
    (Date:12/25/2014)... Newton, North Carolina (PRWEB) December 25, 2014 ... a North Carolina Retirement Community, recently showed their ... and girls of the Catawba County Parenting Network- ... meal, the 10 children gathered around the largest ... community to open presents purchased by residents of ...
    Breaking Medicine News(10 mins):Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:Retirement Community Residents Make Impact During Holiday Season 2
    ... and Eliza Hall,Institute of Medical Research (WEHI) announced ... a leading biotechnology company,based in South San Francisco ... to discover new anti-cancer drugs., "This exciting ... field may increase the chance of translating basic ...
    ... growing away-from-home ... washroom ... announced it has signed a definitive agreement to acquire,Technical Concepts ... hygiene systems for several high-growth,segments of the away-from-home ("AFH") washroom ...
    ... High-Performance ... Academia, SOUTHPOINTE, Pa., Feb. 27 ANSYS, ... simulation software and technologies,designed to optimize product development ... and Technology Information (KISTI), one of,the world,s largest ...
    ... To Enhance Body, Mind & Spirit, VAIL, ... approach to healthcare, Next Step(R) Institute of Integrative,Medicine, ... Colorado, has recently announced its 2008 series of ... Next Step(R) Institute Wellness Weeks are six-night, five-day ...
    ... popular among,30-somethings who don,t want to look a ... somethings who,d like to look 40 again, StriVectin(R)-HS,Hydro-Thermal ... as the only,"great" beauty serum for older complexions ... just published "beauty serum" ranking., (Photo: ...
    ... Two emergency care training,organizations acquired by a single ... created parent company at the helm -- and aggressive ... The Riverside Company, which purchased the American Safety & ... over a year,ago, recently created parent company, the Health ...
    Cached Medicine News:Health News:Abbott, Genentech and WEHI Collaborate to Research and Develop New Anti-Cancer Drugs 2Health News:Newell Rubbermaid to Grow Commercial Products Platform with Agreement to Acquire Technical Concepts 2Health News:Newell Rubbermaid to Grow Commercial Products Platform with Agreement to Acquire Technical Concepts 3Health News:Newell Rubbermaid to Grow Commercial Products Platform with Agreement to Acquire Technical Concepts 4Health News:KISTI Selects ANSYS as a Key Supplier in Engineering Simulation 2Health News:KISTI Selects ANSYS as a Key Supplier in Engineering Simulation 3Health News:KISTI Selects ANSYS as a Key Supplier in Engineering Simulation 4Health News:Next Step(R) Institute of Integrative Medicine, Inc. Takes Wellness to a New Level With 2008 Series of Wellness Weeks 2Health News:Next Step(R) Institute of Integrative Medicine, Inc. Takes Wellness to a New Level With 2008 Series of Wellness Weeks 3Health News:Next Step(R) Institute of Integrative Medicine, Inc. Takes Wellness to a New Level With 2008 Series of Wellness Weeks 4Health News:America's StriVectin the Only 'Great' Serum for Mature, Aging Complexions, Says Leading British Newspaper 2Health News:New Health & Safety Institute Creates Extensive, Centralized Resource for Emergency Care Training 2
    Guaranteed leak-proof , Teflon coating is impervious to corrosive materials , Shock-resistant , NBS tolerances of accuracy , Thermometers are 225 mm long with an immersion length of 35 mm ...
    ... laboratory system for pH and temperature measurements. ... when used with a temperature probe (ATC) ... easy one and two-point calibration with Auto-Find ... 1.68, 4.00, 7.00, 10.01 and 12.45) and ...
    ... The DTX Series Multimode Detectors provide ... variety of application and automation needs. ... absorbance measurements on the same instrument, ... standalone instruments or can be integrated ...
    ... Expert: Detection of PCR, cDNA and Oligonucleotides ... microplate reader for a variety applications that are ... is suitable to handle assays in Microplate ... PCR tubes Cuvettes Independent whether ...
    Medicine Products: